Close

Shorting Herbalife (HLF) is 'Absurdly Risky', Says Pivotal Research

May 6, 2016 8:05 AM EDT Send to a Friend
Pivotal Research maintained a Buy rating on Herbalife (NYSE: HLF) with a price target of $90. Comments follow the release ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login